OpGen

OpGen ROA

The Return on Assets (ROA) of OpGen (OPGN) as of Oct 22, 2026 is 62.07 %. In the previous year, Return on Assets (ROA) was 121.60 % — a change of -48.96% (lower).

ROA

62.07 %

YoY

-48.96%

Last updated:

In 2025, OpGen's return on assets (ROA) was 62.07 %, a -48.96% increase from the 121.60 % ROA in the previous year.

The OpGen ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-149.36 USD
Jan 1, 2019
-119.42 USD
Jan 1, 2020
-52.68 USD
Jan 1, 2021
-48.57 USD
Jan 1, 2022
-144.34 USD
Jan 1, 2023
-1,735.61 USD
Jan 1, 2024
121.60 USD
Jan 1, 2025
62.07 USD
The OpGen ROA history
YEARROAYoY
62.07 %-48.96%
121.60 %-107.01%
-1,735.61 %+1,102.48%
-144.34 %+197.19%
-48.57 %-7.82%
-52.68 %-55.88%
-119.42 %-20.04%
-149.36 %-35.77%
-232.52 %+8.99%
-213.34 %+69.21%
-126.08 %-40.97%
-213.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen, Inc. generates revenue through its Acuitas-branded high-resolution DNA tests and bioinformatics solutions, targeting healthcare providers and hospitals globally. The company's molecular diagnostics and informatics products help combat infectious diseases by providing precise diagnostic information on life-threatening infections and multidrug-resistant microorganisms. These solutions guide clinicians in managing patient outcomes and hospital biome protection through customized screening and surveillance. The firm's DNA tests and bioinformatics address antibiotic resistance, offering data-driven insights for healthcare decision-making. The company's Acuitas trade name is used for its high-resolution DNA tests, which are marketed to healthcare settings focused on infectious disease management. OpGen's products help hospitals manage patient care decisions and protect against the spread of infections caused by multidrug-resistant pathogens. The firm's global network of customers and partners includes healthcare providers seeking to implement pathogen surveillance systems for improved infection control. OpGen's business model centers on delivering molecular information solutions that combine DNA testing with bioinformatics, creating a comprehensive approach to infectious disease management. The company's focus on antibiotic resistance and multidrug-resistant microorganisms drives demand for its Acuitas products, which are positioned as tools for guiding clinical decisions and optimizing hospital infection control protocols. OpGen is one of the most popular companies on Eulerpool.

ROA Details

Understanding OpGen's Return on Assets (ROA)

OpGen's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing OpGen's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider OpGen's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in OpGen’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about OpGen stock

Return on Assets (ROA) of OpGen is 62.07 % in 2025.

Return on Assets (ROA) of OpGen changed from 121.60 % to 62.07 %, representing a -48.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) OpGen since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s OpGen with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — OpGen

All Key Metrics — OpGen